Yg1699, A Novel Dual Systemic Sglt1 And Sglt2 Inhibitor, Decreases Blood Glucose And Improves Kidney Function In Primates With Diabetic Kidney Disease C. Li, R. Xu, H. Wang,P. Strumph,J. He, D. LiDIABETOLOGIA（2021）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
